VYCOR MEDICAL INC (VYCO) › Cash & EquivalentsVYCOR MEDICAL INC (VYCO) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2009-12-31: $12.8K2010-12-31: $127.1K2011-12-31: $950.8K2012-12-31: $59.8K2013-12-31: $31.3K2014-12-31: $1.89M2015-12-31: $347.5K2016-12-31: $56.9K2017-12-31: $206.2K2018-12-31: $86.5K2019-12-31: $60.7K2020-12-31: $46.0K2021-12-31: $90.9K2022-12-31: $37.0K2023-12-31: $57.3K2024-12-31: $105.6K2025-12-31: $87.0K$87.0K2009-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$87.0K-17.7%2026-03-31Balance as of period end2024-12-31$105.6K+84.4%2026-03-31Balance as of period end2023-12-31$57.3K+54.7%2025-04-15Balance as of period end2022-12-31$37.0K-59.3%2024-04-16Balance as of period end2021-12-31$90.9K+97.7%2023-04-14Balance as of period end2020-12-31$46.0K-24.2%2022-04-13Balance as of period end2019-12-31$60.7K-29.8%2021-03-31Balance as of period end2018-12-31$86.5K-58.1%2020-03-27Balance as of period end2017-12-31$206.2K+262.7%2019-03-29Balance as of period end2016-12-31$56.9K-83.6%2019-03-29Balance as of period end2015-12-31$347.5K-81.6%2018-03-30Balance as of period end2014-12-31$1.89M+5943.1%2017-03-31Balance as of period end2013-12-31$31.3K-47.7%2015-03-31Balance as of period end2012-12-31$59.8K-93.7%2015-03-31Balance as of period end2011-12-31$950.8K+648.2%2014-04-07Balance as of period end2010-12-31$127.1K+895.1%2013-04-01Balance as of period end2009-12-31$12.8K—2012-03-30Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)